Information for the public
Why has NICE said this?
NICE looks at how well treatments work in relation to how much they cost compared with other treatments available on the NHS.
NICE applies special considerations to treatments that can extend the lives of people who are nearing the end of their life. Olaparib was recommended for people who have had 3 or more courses of platinum-based chemotherapy because the costs are justified by the benefits it provides, when the special considerations are applied.